IUKL Library
Normal view MARC view ISBD view

Elegibilidade Dos Contraceptivos para Mulheres Com Alto Risco de Infec�c�ao Pelo HIV. Diretriz : Recomenda�c�oes Sobre o Uso de M�etodos Contraceptivos Por Mulheres Com Alto Risco de Infec�c�ao Pelo HIV.

Material type: materialTypeLabelBookPublisher: Geneva : World Health Organization, 2020Copyright date: �2020Edition: 1st ed.Description: 1 online resource (40 pages).Content type: text Media type: computer Carrier type: online resourceISBN: 9789240004603.Genre/Form: Electronic books.Online resources: Click to View
Contents:
Intro -- Acknowledgements -- Executive summary -- background -- Methods of guideline review and development -- 2.1 Guideline Development Group -- 2.2 Guideline development process -- 2.3 Evidence Retrieval -- 3.6 Additional evidence considered by the GDG -- 3.6.1 Biological data -- 3.4 Intrauterine devices -- 3.3 Progestogen-only pills -- 3.2 Progestogen-only implants -- 3.1 Progestogen-only injectables -- 2.5 Recommendation formulation -- 2.4 Evidence Synthesis -- 4.2 Rationale -- 4.1 Recommendations for contraceptive use among women at high risk of HIV infection -- 3.6.2 Values and preferences of contraceptive users -- 3.5 Combined hormonal contraceptives -- Implications for policy-makers, programme managers and health-care providers -- 5.1 A woman's risk of HIV should not restrict her contraceptive choice -- 5.2 Efforts to expand access to contraceptive options must continue -- 5.3 A renewed emphasis on HIV and STI prevention services is urgently needed -- 6.1 Contraceptive methods and HIV acquisition -- 6.2 HIV prevention -- 6.4 Increased funding for high-quality, policy-relevant research -- 6.3 Community involvement -- References -- Annex 1. Guideline Development Group and evidence secretariat -- Annex 2. Declarations of conflicts of interest -- Annex 3. GRADE evidence profiles -- Annex 4. Evidence-to- decision table for hormonal contraceptive methods and intrauterine devices (IUDs) -- Annex 5: Systematic reviews.
Tags from this library: No tags from this library for this title. Log in to add tags.
Item type Current location Collection Call number Copy number Status Date due Item holds
E-book E-book IUKL Library
Subscripti 1 Available
Total holds: 0

Intro -- Acknowledgements -- Executive summary -- background -- Methods of guideline review and development -- 2.1 Guideline Development Group -- 2.2 Guideline development process -- 2.3 Evidence Retrieval -- 3.6 Additional evidence considered by the GDG -- 3.6.1 Biological data -- 3.4 Intrauterine devices -- 3.3 Progestogen-only pills -- 3.2 Progestogen-only implants -- 3.1 Progestogen-only injectables -- 2.5 Recommendation formulation -- 2.4 Evidence Synthesis -- 4.2 Rationale -- 4.1 Recommendations for contraceptive use among women at high risk of HIV infection -- 3.6.2 Values and preferences of contraceptive users -- 3.5 Combined hormonal contraceptives -- Implications for policy-makers, programme managers and health-care providers -- 5.1 A woman's risk of HIV should not restrict her contraceptive choice -- 5.2 Efforts to expand access to contraceptive options must continue -- 5.3 A renewed emphasis on HIV and STI prevention services is urgently needed -- 6.1 Contraceptive methods and HIV acquisition -- 6.2 HIV prevention -- 6.4 Increased funding for high-quality, policy-relevant research -- 6.3 Community involvement -- References -- Annex 1. Guideline Development Group and evidence secretariat -- Annex 2. Declarations of conflicts of interest -- Annex 3. GRADE evidence profiles -- Annex 4. Evidence-to- decision table for hormonal contraceptive methods and intrauterine devices (IUDs) -- Annex 5: Systematic reviews.

Description based on publisher supplied metadata and other sources.

Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2024. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries.

There are no comments for this item.

Log in to your account to post a comment.
The Library's homepage is at http://library.iukl.edu.my/.